JP2020530777A5 - - Google Patents

Info

Publication number
JP2020530777A5
JP2020530777A5 JP2020520429A JP2020520429A JP2020530777A5 JP 2020530777 A5 JP2020530777 A5 JP 2020530777A5 JP 2020520429 A JP2020520429 A JP 2020520429A JP 2020520429 A JP2020520429 A JP 2020520429A JP 2020530777 A5 JP2020530777 A5 JP 2020530777A5
Authority
JP
Japan
Prior art keywords
domain
scfv domain
quadruspecific
binding specificity
percentage homology
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020520429A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020530777A (ja
JP7399852B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/039156 external-priority patent/WO2019005639A2/en
Publication of JP2020530777A publication Critical patent/JP2020530777A/ja
Publication of JP2020530777A5 publication Critical patent/JP2020530777A5/ja
Application granted granted Critical
Publication of JP7399852B2 publication Critical patent/JP7399852B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020520429A 2017-06-25 2018-06-22 多重特異性抗体とその作製及び使用方法 Active JP7399852B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762524557P 2017-06-25 2017-06-25
US62/524,557 2017-06-25
PCT/US2018/039156 WO2019005639A2 (en) 2017-06-25 2018-06-22 MULTISPECIFIC ANTIBODIES AND METHODS OF PREPARATION AND USE THEREOF

Publications (3)

Publication Number Publication Date
JP2020530777A JP2020530777A (ja) 2020-10-29
JP2020530777A5 true JP2020530777A5 (cg-RX-API-DMAC7.html) 2022-02-07
JP7399852B2 JP7399852B2 (ja) 2023-12-18

Family

ID=64742644

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020520429A Active JP7399852B2 (ja) 2017-06-25 2018-06-22 多重特異性抗体とその作製及び使用方法

Country Status (10)

Country Link
US (1) US11787863B2 (cg-RX-API-DMAC7.html)
EP (1) EP3645049A4 (cg-RX-API-DMAC7.html)
JP (1) JP7399852B2 (cg-RX-API-DMAC7.html)
KR (2) KR20250024104A (cg-RX-API-DMAC7.html)
CN (4) CN116199785A (cg-RX-API-DMAC7.html)
AU (2) AU2018295118B2 (cg-RX-API-DMAC7.html)
CA (1) CA3068045A1 (cg-RX-API-DMAC7.html)
IL (2) IL313468A (cg-RX-API-DMAC7.html)
SG (1) SG11201912864SA (cg-RX-API-DMAC7.html)
WO (1) WO2019005639A2 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20260008861A9 (en) * 2017-06-25 2026-01-08 Systimmune, Inc. Anti-4-1bb antibodies and methods of making and using thereof
SG11201912865VA (en) * 2017-06-25 2020-01-30 Systimmune Inc Multi-specific antibodies and methods of making and using thereof
JP7383605B2 (ja) * 2017-06-25 2023-11-20 システィミューン, インク. 抗pd-l1抗体とその作製及び使用方法
TW201904588A (zh) * 2017-06-25 2019-02-01 美商西雅圖免疫公司 引導及導航控制蛋白質之製造及使用方法
EP3773621A4 (en) * 2018-03-27 2022-03-23 Systimmune, Inc. GUIDANCE AND NAVIGATION CONTROL PROTEINS AND METHODS FOR THEIR MANUFACTURE AND USE
UY38701A (es) 2019-05-21 2020-12-31 Novartis Ag Moléculas de unión a cd19, conjugados, composiciones que las comprenden y usos de las mismas
AU2020279224B2 (en) 2019-05-21 2024-12-05 Novartis Ag Trispecific binding molecules against BCMA and uses thereof
CN118580364A (zh) * 2019-11-06 2024-09-03 西雅图免疫公司 制导和导航控制蛋白及其制备和使用方法
EP3988568A1 (en) * 2020-10-21 2022-04-27 Numab Therapeutics AG Combination treatment
CN118974091A (zh) * 2022-04-11 2024-11-15 阿斯利康(瑞典)有限公司 T细胞结合蛋白
CA3262028A1 (en) * 2022-07-15 2025-06-13 Abl Bio Inc. Anti-ROR1 antibodies, bispecific antibodies containing it, and their uses
CN120813602A (zh) * 2022-12-20 2025-10-17 英克特诺治疗公司 用于治疗癌症的组合疗法
US20240294651A1 (en) 2023-01-30 2024-09-05 Kymab Limited Antibodies
CN116143934B (zh) * 2023-03-21 2023-07-25 诺赛联合(北京)生物医学科技有限公司 一种干细胞外泌体提取试剂盒及其应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1392359T4 (da) 2001-05-11 2013-06-10 Ludwig Inst For Cancer Res Ltd Specifikke bindingsproteiner og deres anvendelser.
CA2832136C (en) * 2002-09-27 2015-11-17 Xencor Optimized fc variants and methods for their generation
WO2007002223A2 (en) * 2005-06-20 2007-01-04 Medarex, Inc. Cd19 antibodies and their uses
US8679502B2 (en) 2007-11-13 2014-03-25 Evec Inc. Monoclonal antibodies that bind to HGM-CSF and medical compositions comprising same
US9365644B2 (en) * 2008-04-23 2016-06-14 Epitomics, Inc. Anti-TNFα antibody
BRPI1014089A2 (pt) 2009-04-02 2016-04-19 Roche Glycart Ag anticorpos multiespecíficos que compreendem anticorpos de comprimento completo e fragmentos fab de cadeia simples
SG176219A1 (en) * 2009-05-27 2011-12-29 Hoffmann La Roche Tri- or tetraspecific antibodies
GB201020995D0 (en) * 2010-12-10 2011-01-26 Bioinvent Int Ab Biological materials and uses thereof
CN103906533A (zh) * 2011-11-07 2014-07-02 米迪缪尼有限公司 多特异性和多价结合蛋白及其用途
PL3489261T3 (pl) * 2012-08-24 2021-08-16 The Regents Of The University Of California Przeciwciała i szczepionki do stosowania w leczeniu nowotworów z ekspresją ROR1 i w hamowaniu przerzutu
US9732150B2 (en) * 2013-03-14 2017-08-15 Alderbio Holdings Llc Therapeutic use of antibodies to HGF
HK1218549A1 (zh) 2013-06-26 2017-02-24 Numab Therapeutics AG 新型抗体框架
JP6693872B2 (ja) * 2013-07-25 2020-05-13 シトムクス セラピューティクス,インコーポレイティド 多重特異性抗体、多重特異性活性化可能抗体、及びそれらの使用方法
WO2015058861A1 (en) 2013-10-25 2015-04-30 Numab Ag Bispecific constructs and their use in the treatment of various diseases
CA3265373A1 (en) * 2014-02-20 2025-10-30 H. Lundbeck A/S Anti-acth antibodies and use thereof
UA117289C2 (uk) * 2014-04-02 2018-07-10 Ф. Хоффманн-Ля Рош Аг Мультиспецифічне антитіло
US10428155B2 (en) * 2014-12-22 2019-10-01 Xencor, Inc. Trispecific antibodies
EP3253790A4 (en) * 2015-02-06 2018-07-25 University of Maryland, Baltimore Tetra-specific, octameric binding agents and antibodies against clostridium difficile toxin a and toxin b for treatment of c. difficile infection
CN104829733B (zh) * 2015-05-25 2018-06-05 广州百暨基因科技有限公司 抗原结合单元稳定的嵌合抗原受体及制备方法与应用
JP6932700B2 (ja) * 2015-09-15 2021-09-08 アムジエン・インコーポレーテツド 4価の二重特異性抗原結合タンパク質及び4価の四重特異性抗原結合タンパク質、ならびにそれらの使用
TW201904588A (zh) * 2017-06-25 2019-02-01 美商西雅圖免疫公司 引導及導航控制蛋白質之製造及使用方法
SG11201912865VA (en) 2017-06-25 2020-01-30 Systimmune Inc Multi-specific antibodies and methods of making and using thereof
EP3773621A4 (en) * 2018-03-27 2022-03-23 Systimmune, Inc. GUIDANCE AND NAVIGATION CONTROL PROTEINS AND METHODS FOR THEIR MANUFACTURE AND USE

Similar Documents

Publication Publication Date Title
JP2020530306A5 (cg-RX-API-DMAC7.html)
JP2020529864A5 (cg-RX-API-DMAC7.html)
JP7685095B2 (ja) 多重特異性抗体とその作製及び使用方法
JP7399852B2 (ja) 多重特異性抗体とその作製及び使用方法
TWI874613B (zh) 微型導引和導航控制(miniGNC)類抗體蛋白及其製造和使用方法
CN117285641A (zh) 制导和导航控制蛋白及其制备和使用方法
JP2021519072A5 (cg-RX-API-DMAC7.html)
JP2022551081A (ja) 癌処置のための多重特異性結合タンパク質
JP2021501575A (ja) 二重特異性抗体並びにその製造方法及び使用方法
CN117222672A (zh) 抗cldn4-抗cd137双特异性抗体
Li et al. Advancing immunotherapy via multiple immune cells co-engagement
HK40093821A (en) Multi-specific antibodies and methods of making and using thereof
HK40088418A (en) Multi-specific antibodies and methods of making and using thereof
HK40088417A (en) Multi-specific antibodies and methods of making and using thereof
HK40111322A (en) Multi-specific antibodies and methods of making and using thereof
HK40111323A (en) Multi-specific antibodies and methods of making and using thereof
HK40097105A (en) Bispecific antibodies and methods of making and using thereof
WO2025064498A1 (en) Affinity-modulated anti-cd45 x pd-1 and anti-cd43 x pd-1 bispecific antibodies to treat cancer and autoimmunity
NZ760913B2 (en) Multi-specific antibodies and methods of making and using thereof
HK40109798A (en) Guidance and navigation control proteins and method of making and using thereof
TW202434635A (zh) 多特異性抗體及其醫藥用途
HK40097671A (en) Guidance and navigation control proteins and method of making and using thereof
HK40097672A (en) Guidance and navigation control proteins and method of making and using thereof
HK40018991A (en) Multi-specific antibodies and methods of making and using thereof
HK40019010A (en) Multi-specific antibodies and methods of making and using thereof